Want to see ETST full AI Analyst Report?
Top Page
Earth Science Tech
(OTC:ETST)
Select Model
Select Model
Rating:64Neutral
Price Target:
$0.10
▲(6.67% Upside)
Action:Reiterated
Date:09/06/26
ETST scores as moderately attractive primarily due to improving financial footing (solid margins, positive operating/FCF, very low leverage) and supportive corporate actions (expansion acquisitions and governance/uplisting initiatives). The main drag is weak technicals—price below key moving averages with negative MACD—alongside the material TTM revenue decline and historically volatile cash generation.
Positive Factors
Healthy profitability
Healthy gross and net margins indicate that ETST is currently converting its healthcare and wellness activities into meaningful earnings. If maintained, this profitability can support reinvestment, strengthen resilience during uneven growth periods, and provide greater flexibility to fund expansion without relying heavily on external capital.
Negative Factors
Revenue contraction
The sharp TTM revenue decline indicates that ETST’s demand and scaling trajectory has weakened despite solid current margins. Prolonged top-line contraction could reduce operating leverage, limit reinvestment capacity, and make it harder for recent acquisitions and new healthcare initiatives to translate into consistent long-term growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy profitability
Healthy gross and net margins indicate that ETST is currently converting its healthcare and wellness activities into meaningful earnings. If maintained, this profitability can support reinvestment, strengthen resilience during uneven growth periods, and provide greater flexibility to fund expansion without relying heavily on external capital.
Read all positive factors
Earth Science Tech (ETST) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$25.88M
Dividend YieldN/A
Average Volume (3M)179.38K
Price to Earnings (P/E)6.8
Beta (1Y)2.25
Revenue Growth7.96%
EPS Growth51.14%
CountryUS
Employees77
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)0.01
Shares Outstanding287,590,880
10 Day Avg. Volume152,527
30 Day Avg. Volume179,384
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)3.71
Price to Sales (P/S)0.73
P/FCF Ratio21.98
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)$42.99M
Earth Science Tech Business Overview & Revenue Model
Company Description
Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements. These offerings aim to support general health, overall well-being, nutrition, ...
Earth Science Tech Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
67
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Jun 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.96M | 35.70M | 33.12M | 11.95M | 48.54K | 14.12K |
| Gross Profit | 19.34M | 25.49M | 24.30M | 7.83M | 22.06K | -8.52K |
| EBITDA | 4.94M | 3.39M | 3.54M | 1.47M | -382.19K | -219.21K |
| Net Income | 3.89M | 3.63M | 3.25M | 812.14K | -365.40K | 3.17M |
Balance Sheet | ||||||
| Total Assets | 10.37M | 8.97M | 7.07M | 3.88M | 2.73M | 76.94K |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 2.16M | 2.12M | 697.72K | 35.76K | 26.94K |
| Total Debt | 353.16K | 96.21K | 401.24K | 246.59K | 974.11K | 780.69K |
| Total Liabilities | 3.01M | 1.93M | 3.22M | 1.63M | 1.61M | 1.88M |
| Stockholders Equity | 7.34M | 7.01M | 3.85M | 2.25M | 1.12M | -1.81M |
Cash Flow | ||||||
| Free Cash Flow | 1.74M | 1.18M | 3.62M | 1.18M | -1.01M | -166.39K |
| Operating Cash Flow | 2.31M | 1.94M | 4.37M | 1.21M | -1.01M | -168.11K |
| Investing Cash Flow | -1.72M | -1.90M | -1.88M | -26.52K | 0.00 | 1.71K |
| Financing Cash Flow | -838.30K | -712.92K | -1.72M | -517.88K | 1.02M | 173.18K |
Earth Science Tech Technical Analysis
Negative
0.09
Price Trends
0.12
Negative
0.14
Negative
0.14
Negative
Market Momentum
>-0.01
Negative
42.76
Neutral
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.12, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.76 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.
Earth Science Tech Risk Analysis
Earth Science Tech disclosed 38 risk factors in its most recent earnings report. Earth Science Tech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Earth Science Tech Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $25.88M | 6.77 | 62.03% | ― | 7.96% | 51.14% | |
59 Neutral | $32.18M | -5.74 | -14.03% | ― | -21.12% | -109.07% | |
52 Neutral | $62.29M | -3.76 | -87.28% | ― | -96.30% | 35.57% | |
52 Neutral | $101.74M | -9.50 | -47.10% | 20.41% | -25.68% | -244.92% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $52.73M | -2.88 | -21.10% | ― | 489.78% | 45.39% | |
49 Neutral | $27.49M | -0.41 | -118.89% | ― | 33.82% | 34.05% |
* Healthcare Sector Average
ETST
Earth Science Tech
0.09
-0.10
-52.63%
TLPH
Talphera
1.20
0.38
46.52%
RMTI
Rockwell Med
7.99
-7.92
-49.78%
SCYX
SCYNEXIS
5.30
-2.04
-27.75%
CPIX
Cumberland Pharmaceuticals
6.79
4.22
164.61%
COSM
Cosmos Holdings
0.27
-0.34
-55.39%
Earth Science Tech Corporate Events
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesShareholder MeetingsStock Split
Earth Science Tech Shareholders Back Governance and Uplisting Plan
Positive
Sep 1, 2026
Earth Science Tech, Inc. held its first annual meeting of stockholders virtually on August 31, 2026, where shareholders re-elected all seven directors and ratified Semple, Marchal Cooper, LLP as the independent registered public accounting firm f...
Business Operations and StrategyM&A Transactions
Earth Science Tech Acquires Zoolzy to Expand Healthcare Operations
Positive
Aug 19, 2026
On August 19, 2026, Earth Science Tech, Inc. announced it had acquired Zoolzy LLC, a Doral, Florida-based wholesale distributor of active pharmaceutical ingredients and finished FDA-approved prescription products operating from a 3,684-square-foot...
Business Operations and StrategyM&A Transactions
Earth Science Tech Expands Footprint With Meduvo Acquisition
Positive
Aug 12, 2026
On August 11, 2026, Earth Science Tech, Inc. entered into an agreement to acquire Meduvo LLC, a compounding pharmacy based in La Verne, California, in a transaction deemed immaterial in size. The deal was structured as a related-party transaction ...
Business Operations and StrategyStock BuybackFinancial DisclosuresRegulatory Filings and Compliance
Earth Science Tech Highlights Transformational Debt-Free Growth Strategy
Positive
Jun 10, 2026
Earth Science Tech, Inc., a Miami-based strategic holding company in the health and wellness space, reported that the fiscal year ended March 31, 2026, was transformational as it advanced a vertically integrated healthcare model spanning telemedic...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.